Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
United Therapeutics Insider Sold Shares Worth $5,700,856, According to a Recent SEC Filing

United Therapeutics Insider Sold Shares Worth $5,700,856, According to a Recent SEC Filing

MT newswireMT newswire2026/11/02 20:37
04:37 PM EST, 11/02/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on October 30, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,700,856. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000176/xslF345X05/primarydocument.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

OPay backed by SoftBank suddenly halts US IPO, regulatory inquiries become the biggest uncertainty

Nigerian digital financial platform OPay announced the suspension of its IPO after revealing pricing, citing a regulatory inquiry. The company stated that the listing may be restarted in the coming months.

智通财经•2026/11/03 07:57
OPay backed by SoftBank suddenly halts US IPO, regulatory inquiries become the biggest uncertainty